gene

DR5

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about DR5: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

106Connections
0Hypotheses
0Analyses
50Outgoing
38Incoming

Summary

DR5 is a gene implicated in neurodegeneration research. Key relationships include: therapeutic target, inhibits, activates. Associated with ALS, Als, Breast Cancer. Connected to 59 entities in the SciDEX knowledge graph.

View on Wiki →

🧬 Gene Info
Gene SymbolDR5
Chromosome5q35.1
Protein TypeReceptor
Functionis an important component in the neurobiology of neurodegenerative diseases.
Molecular Weight52.9 kDa
Amino Acids477 aa
PathwaysAkt, Apoptosis, Cell Cycle, Pi3K
UniProt IDP21918
NCBI Gene ID1816
Ensembl IDENSG00000169679
GeneCardsDR5
Human Protein AtlasDR5
Amino acids446
D5 has 31 additional residues in C-terminus| D5 has higher basal activity (constitutive activity)
D5 has higher dopamine affinity (~10-fold)| D5 mRNA shows more widespread brain distribution
Associated DiseasesALS
InteractionsEGFR, BAD, AKT, JUN, PI3K, JNK
KG Connections106 knowledge graph edges
DatabasesGeneCardsHPASTRING
🔮 Predicted Structure: DR5 — AlphaFold P21918 Click to expand

AI-predicted structure from AlphaFold | Powered by Mol*

Wiki Pages (21)

Knowledge base pages for this entity

Canonical Page

DRD5 Gene — Dopamine Receptor D5

gene · 1940 words

Unfolded Protein Response (UPR)

mechanism · 3651 words

Apoptosis Pathway in Neurodegeneration

mechanism · 3169 words

Apoptosis in Neurodegeneration

mechanism · 3147 words

ER Stress in Corticobasal Syndrome

mechanism · 3015 words

TRAIL Gene (TNFSF10)

gene · 2784 words

Pathway Diagram

graph TD
    DR5["<b>DR5</b>"]
    Cancer{"Cancer"}
    DR5 -->|"activates"| Cancer
    Tumor{"Tumor"}
    DR5 -->|"activates"| Tumor
    Als{"Als"}
    DR5 -->|"inhibits"| Als
    DR5 -->|"activates"| Als
    Lymphoma{"Lymphoma"}
    DR5 -->|"therapeutic target"| Lymphoma
    DR5 -->|"therapeutic target"| Als
    Ms{"Ms"}
    DR5 -->|"therapeutic target"| Ms
    DR5 -->|"therapeutic target"| Cancer
    ALS{"ALS"}
    DR5 -->|"inhibits"| ALS
    EGFR["EGFR"]
    DR5 -->|"activates"| EGFR
    BAD["BAD"]
    DR5 -->|"inhibits"| BAD
    Pi3K(["Pi3K"])
    DR5 -->|"inhibits"| Pi3K
    JUN["JUN"]
    JUN -->|"inhibits"| DR5
    ERK["ERK"]
    ERK -->|"inhibits"| DR5
    PI3K["PI3K"]
    PI3K -->|"inhibits"| DR5
    EGFR -->|"activates"| DR5
    BAD -->|"inhibits"| DR5
    AKT["AKT"]
    AKT -->|"activates"| DR5
    C_JUN["C-JUN"]
    C_JUN -->|"activates"| DR5
    P53["P53"]
    P53 -->|"therapeutic target"| DR5
    CANCER["CANCER"]
    CANCER -->|"therapeutic target"| DR5
    APOPTOSIS["APOPTOSIS"]
    APOPTOSIS -->|"therapeutic target"| DR5
    style DR5 fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0

Outgoing (68)

TargetRelationTypeStr
Cancertherapeutic_targetdisease0.75
Canceractivatesdisease0.65
Tumoractivatesdisease0.65
Alsinhibitsdisease0.65
Alsactivatesdisease0.65

Incoming (38)

SourceRelationTypeStr
CANCERtherapeutic_targetgene0.70
BCL-2therapeutic_targetgene0.70
JUNinhibitsgene0.60
PI3Kinhibitsgene0.60
EGFRactivatesgene0.60

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found